Health Canada Wants More Funds from Pharma
Lauren Vogel Health policy experts told CMAJ that parliamentary oversight of cost recovery is particularly important given the potential for conflicts of interest as Canada looks to increase its dependence on industry fees. “The more you get your money from a private source, the more you may consciously or unconsciously see yourself as being in […]
Why are Standards So Lax on Covid Drugs Approval?
Vinay Prasad Many scientists made a career fighting for better regulatory standards. Strangely, when it comes to the regulatory policy around COVID-19, they are dead quiet. First, consider that EUA ( emergency use authorization ) is like accelerated approval. Both require lower levels of evidence, and are predicated on the fact that we’re dealing with […]
